BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30305146)

  • 1. A study of target effect sizes in randomised controlled trials published in the Health Technology Assessment journal.
    Rothwell JC; Julious SA; Cooper CL
    Trials; 2018 Oct; 19(1):544. PubMed ID: 30305146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review.
    Cook JA; Hislop J; Adewuyi TE; Harrild K; Altman DG; Ramsay CR; Fraser C; Buckley B; Fayers P; Harvey I; Briggs AH; Norrie JD; Fergusson D; Ford I; Vale LD
    Health Technol Assess; 2014 May; 18(28):v-vi, 1-175. PubMed ID: 24806703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme.
    Walters SJ; Bonacho Dos Anjos Henriques-Cadby I; Bortolami O; Flight L; Hind D; Jacques RM; Knox C; Nadin B; Rothwell J; Surtees M; Julious SA
    BMJ Open; 2017 Mar; 7(3):e015276. PubMed ID: 28320800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA
    Cook JA; Julious SA; Sones W; Hampson LV; Hewitt C; Berlin JA; Ashby D; Emsley R; Fergusson DA; Walters SJ; Wilson EC; MacLennan G; Stallard N; Rothwell JC; Bland M; Brown L; Ramsay CR; Cook A; Armstrong D; Altman D; Vale LD
    Health Technol Assess; 2019 Oct; 23(60):1-88. PubMed ID: 31661431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme.
    Raftery J; Young A; Stanton L; Milne R; Cook A; Turner D; Davidson P
    Health Technol Assess; 2015 Feb; 19(11):1-138. PubMed ID: 25671821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies.
    Sully BG; Julious SA; Nicholl J
    Trials; 2013 Jun; 14():166. PubMed ID: 23758961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study.
    Blatch-Jones AJ; Pek W; Kirkpatrick E; Ashton-Key M
    BMJ Open; 2018 Sep; 8(9):e022233. PubMed ID: 30257847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trials in non-pharmacological rehabilitation research: a scoping review of the reporting of sample size calculation, randomization procedure, and statistical analyses.
    Amiri M; Kumbhare D
    Eur J Phys Rehabil Med; 2020 Dec; 56(6):790-798. PubMed ID: 32935956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.
    Hislop J; Adewuyi TE; Vale LD; Harrild K; Fraser C; Gurung T; Altman DG; Briggs AH; Fayers P; Ramsay CR; Norrie JD; Harvey IM; Buckley B; Cook JA;
    PLoS Med; 2014 May; 11(5):e1001645. PubMed ID: 24824338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls in reporting sample size calculation in randomized controlled trials published in leading anaesthesia journals: a systematic review.
    Abdulatif M; Mukhtar A; Obayah G
    Br J Anaesth; 2015 Nov; 115(5):699-707. PubMed ID: 26041717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA
    Sones W; Julious SA; Rothwell JC; Ramsay CR; Hampson LV; Emsley R; Walters SJ; Hewitt C; Bland M; Fergusson DA; Berlin JA; Altman D; Vale LD; Cook JA
    Trials; 2018 Oct; 19(1):542. PubMed ID: 30305155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of sample sizes in publications of randomised controlled trials on the treatment of age-related macular degeneration: cross-sectional evaluation.
    Tulka S; Geis B; Baulig C; Knippschild S; Krummenauer F
    BMJ Open; 2019 Oct; 9(10):e030312. PubMed ID: 31601589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The completeness of intervention descriptions in published National Institute of Health Research HTA-funded trials: a cross-sectional study.
    Douet L; Milne R; Anstee S; Habens F; Young A; Wright D
    BMJ Open; 2014 Jan; 4(1):e003713. PubMed ID: 24384896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database.
    Billingham SA; Whitehead AL; Julious SA
    BMC Med Res Methodol; 2013 Aug; 13():104. PubMed ID: 23961782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quality of the reported sample size calculations in randomized controlled trials indexed in PubMed.
    Lee PH; Tse ACY
    Eur J Intern Med; 2017 May; 40():16-21. PubMed ID: 27769569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.